Molecular Autism, a new journal published by open access publisher BioMed Central, UK, is now accepting submissions. The journal is edited by Professors Joseph D Buxbaum of the Mount Sinai School of Medicine and Simon Baron-Cohen of University of Cambridge. They will be supported by an expert international Editorial Board.
Molecular Autism seeks to be the major forum for research into the molecular basis of autism and related neurodevelopmental conditions. The journal will focus on research that relates causal and risk factors with these conditions, leading to model systems and novel therapeutics. This will include studies of genetics, neuropathology, neuroimaging, biomarkers, and molecular neurobiology.
The primary focus is on conditions in the autism spectrum (including Asperger syndrome), but the scope also encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.
